Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLAUKOS CorpGKOS · Entity 3510 | Chief Operating Officer | March 24, 2022 | March 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLAUKOS Corp
Report date March 24, 2022 · Filed March 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,594 |
Reported balance
After 2022-03-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-24 · Grant · Acquired 3,886 · Balance 181,594 F1: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the first year of the multi-year performance period. The Reporting Person elected to receive this performance grant in the form of restricted stock units. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement with respect to the first-year performance goal. 50% of the number of shares of common stock reported herein will vest and be delivered on April 6, 2022 and the remaining 50% will vest and be delivered on January 6, 2023. F2: Includes 21,787 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.10 · Expires 2030-03-12 | Direct | 11,301 |
Reported balance
After 2022-03-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-24 · Grant · Acquired 4,917 · Balance 11,301 F3: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the second year of the multi-year performance period. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement with respect to the second-year performance goal. The portion of the option reported herein will vest and become exercisable on April 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the first year of the multi-year performance period. The Reporting Person elected to receive this performance grant in the form of restricted stock units. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement with respect to the first-year performance goal. 50% of the number of shares of common stock reported herein will vest and be delivered on April 6, 2022 and the remaining 50% will vest and be delivered on January 6, 2023.
F2: Includes 21,787 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the second year of the multi-year performance period. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement with respect to the second-year performance goal. The portion of the option reported herein will vest and become exercisable on April 1, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2022 Filed Mar 29, 2022 00:27 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 4,917 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001104659-22-038980 · tm2210670-2_4seq1.xml · derivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,301 Underlying: Common Stock · 4,917 shares Expires 2030-03-12 F3 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the second year of the multi-year performance period. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement with respect to the second-year performance goal. The portion of the option reported herein will vest and become exercisable on April 1, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:27 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-038980 · tm2210670-2_4seq1.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,594 F1 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the first year of the multi-year performance period. The Reporting Person elected to receive this performance grant in the form of restricted stock units. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement with respect to the first-year performance goal. 50% of the number of shares of common stock reported herein will vest and be delivered on April 6, 2022 and the remaining 50% will vest and be delivered on January 6, 2023. F2 · balance_after: Includes 21,787 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 16, 2022 Filed Mar 19, 2022 01:06 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 646 | $48.59 | $31,389.14 |
DisclosureSEC source: 0001104659-22-035761 · tm229831-1_4seq1.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,708 F1 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2019. F2 · balance_after: Includes 17,901 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 23:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 168 | $47.42 | $7,966.56 |
DisclosureSEC source: 0001104659-22-002371 · tm222365-2_4seq1.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,354 F1 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on December 17, 2020. F2 · balance_after: Includes 19,479 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to Buy) · Derivative | 4,562 | $0.00 Strike: $28.78 | $0.00 |
DisclosureSEC source: 0001104659-21-039872 · tm2110536-1_4seq1.xml · derivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,562 Underlying: Common Stock · 4,562 shares Expires 2030-03-12 F6 · shares: Represents an option to purchase shares of common stock previously granted by the Issuer on April 1, 2020 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2020 in the form of stock options rather than cash (the "Bonus Election"). The Compensation Committee determined on March 18, 2021 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2020 executive bonus plan and the number of shares of common stock subject to the stock option earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date. The option to purchase common stock will vest on April 1, 2021. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to Buy) · Derivative | 6,384 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001104659-21-039872 · tm2110536-1_4seq1.xml · derivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,384 Underlying: Common Stock · 6,384 shares Expires 2030-03-12 F5 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 18, 2021 the level of achievement for the first year of the multi-year performance period. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that vested based upon the achievement with respect to the first-year performance goal. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 783 | $89.22 | $69,859.26 |
DisclosureSEC source: 0001104659-21-039872 · tm2110536-1_4seq1.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,522 F3 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2019. F4 · balance_after: Includes 19,888 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 15,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-039872 · tm2110536-1_4seq1.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,305 F1 · shares: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. F2 · balance_after: Includes 21,466 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to Buy) · Derivative | 60,417 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · derivative · entry 6 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,417 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F7 · derivative.exercise_date: This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 16,785 | $89.44 | $1,501,307.47 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · nonDerivative · entry 5 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,806 F6 · price: This transaction was executed in multiple trades at prices ranging from $89.23 to $89.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 24,401 | $88.74 | $2,165,288.62 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,591 F5 · price: This transaction was executed in multiple trades at prices ranging from $88.23 to $89.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 6,030 | $87.79 | $529,345.36 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,992 F4 · price: This transaction was executed in multiple trades at prices ranging from $87.235 to $88.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 13,201 | $86.65 | $1,143,836.29 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,022 F3 · price: This transaction was executed in multiple trades at prices ranging from $86.22 to $87.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:44 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 60,417 | $16.49 | $996,276.33 |
DisclosureSEC source: 0001127602-21-003721 · form4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 17, 2020 Filed Dec 19, 2020 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,233 | $72.99 | $89,996.67 |
DisclosureSEC source: 0001104659-20-137560 · a4.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,806 F3 · security: Granted by the Issuer in the form of restricted stock units which vest over a three-year period, with one-third to vest on each anniversary of the grant date. F4 · balance_after: Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 4,128 | $71.94 | $296,968.32 |
DisclosureSEC source: 0001104659-20-137560 · a4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,573 F1 · shares: Represents shares of common stock subject to a performance-based restricted stock unit award previously granted by the Issuer on March 14, 2019, the vesting of which was subject to the Issuer's achievement of certain performance goals within three years of the grant date. The Compensation Committee of the Issuer's Board of Directors determined on December 16, 2020 that the performance goals had been achieved. The number of shares of common stock reported consists of the 6,311 shares underlying the restricted stock units originally granted less 2,183 shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon the vesting and delivery of the shares of common stock underlying these restricted stock units. F2 · balance_after: Includes 4,734 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 23:27 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 224 | $28.78 | $6,446.72 |
DisclosureSEC source: 0001127602-20-013279 · form4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,445 F1 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on April 1, 2019. F2 · balance_after: Includes 4,734 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:33 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 640 | $33.35 | $21,344.00 |
DisclosureSEC source: 0001127602-20-011343 · form4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,669 F1 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2019. F2 · balance_after: Includes 5,381 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 22:11 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 51,769 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001127602-20-010908 · form4.xml · derivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,769 Underlying: Common Stock · 51,769 shares Expires 2030-03-12 F3 · derivative.exercise_date: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 22:11 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 647 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-010908 · form4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,309 F1 · shares: Represents shares of common stock subject to a restricted stock unit award previously granted by the Issuer on April 1, 2019 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2019 in the form of restricted stock units rather than cash (the "Bonus Election"). The Compensation Committee determined on March 12, 2020 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2019 executive bonus plan and the number of stock units earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date. The restricted stock units will vest on April 1, 2020 and are payable on a one-for-one basis in shares of the Issuer's common stock. F2 · balance_after: Includes 6,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-019728 · a4.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,662 F3 · shares: Consists of shares withheld by the Issuer with respect to income taxes payable by the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on April 1, 2018. F2 · balance_after: Includes 6,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 23:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to Buy) · Derivative | 13,300 | $0.00 Strike: $69.30 | $0.00 |
DisclosureSEC source: 0001104659-19-015708 · a4.xml · derivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,300 Underlying: Common Stock · 13,300 shares Expires 2029-03-14 F3 · derivative.exercise_date: Granted pursuant to the Issuer's 2015 Omnibus Incentive Compensation Plan. Vests over a four-year period, with 25% to vest on the 1st anniversary of the grant date and 1/48th of the total to vest each month thereafter. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 23:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 6,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-015708 · a4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,311 F1 · security: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. F2 · balance_after: Includes 6,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 14, 2019 Filed Apr 3, 2019 21:46 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-019728 · a4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,906 F1 · shares: Represents shares of common stock subject to a restricted stock unit award previously granted by the Issuer on April 1, 2018 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2018 in the form of restricted stock units rather than cash (the "Bonus Election"). The Compensation Committee determined on March 14, 2019 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2018 executive bonus plan and the number of stock units earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date. The restricted stock units vested on April 1, 2019 and are payable on a one-for-one basis in shares of the Issuer's common stock. F2 · balance_after: Includes 6,311 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 23:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 727 | $67.58 | $49,130.66 |
DisclosureSEC source: 0001104659-19-013430 · a4.xml · nonDerivative · entry 5 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F6 · price: This transaction was executed in multiple trades at prices ranging from $67.46 to $67.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 23:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,076 | $66.86 | $272,521.36 |
DisclosureSEC source: 0001104659-19-013430 · a4.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,727 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F5 · price: This transaction was executed in multiple trades at prices ranging from $66.43 to $67.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 23:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 11,801 | $66.02 | $779,102.02 |
DisclosureSEC source: 0001104659-19-013430 · a4.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,803 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · price: This transaction was executed in multiple trades at prices ranging from $65.40 to $66.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 23:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 26,740 | $68.21 | $1,823,935.40 |
DisclosureSEC source: 0001104659-19-013430 · a4.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,604 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $68.12 to $68.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 23:17 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 46,656 | $67.89 | $3,167,475.84 |
DisclosureSEC source: 0001104659-19-013430 · a4.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,344 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.12 to $68.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to buy) · Derivative | 38,983 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001562180-18-003488 · primarydocument.xml · derivative · entry 5 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,417 Underlying: Common Stock · 38,983 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 100 | $46.29 | $4,629.00 |
DisclosureSEC source: 0001562180-18-003488 · primarydocument.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,522 | $45.40 | $205,298.80 |
DisclosureSEC source: 0001562180-18-003488 · primarydocument.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,100 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 34,361 | $44.31 | $1,522,535.91 |
DisclosureSEC source: 0001562180-18-003488 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,622 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $44.00 to $44.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 23:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 38,983 | $16.49 | $642,829.67 |
DisclosureSEC source: 0001562180-18-003488 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to buy) · Derivative | 600 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · derivative · entry 8 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,400 Underlying: Common Stock · 600 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F5 · derivative.exercise_date: This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to buy) · Derivative | 1,870 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · derivative · entry 7 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,870 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option was granted on January 29, 2013, and had a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,470 | $44.03 | $108,754.10 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · nonDerivative · entry 5 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $44.00 to $44.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 600 | $16.49 | $9,894.00 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 1,870 | $4.23 | $7,900.75 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to buy) · Derivative | 7,759 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · derivative · entry 6 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870 Underlying: Common Stock · 7,759 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option was granted on January 29, 2013, and had a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 7,759 | $44.01 | $341,473.59 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $44.00 to $44.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:07 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 7,759 | $4.23 | $32,781.78 |
DisclosureSEC source: 0001562180-18-003073 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 21:53 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to buy) · Derivative | 8,771 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-18-003026 · primarydocument.xml · derivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,629 Underlying: Common Stock · 8,771 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · derivative.exercise_date: This option was granted on January 29, 2013, and had a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 21:53 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 8,771 | $44.01 | $386,011.71 |
DisclosureSEC source: 0001562180-18-003026 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $44.00 to $44.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 21:53 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 8,771 | $4.23 | $37,057.48 |
DisclosureSEC source: 0001562180-18-003026 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 17:02 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to buy) · Derivative | 80,500 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001562180-18-001647 · primarydocument.xml · derivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,500 Underlying: Common Stock · 80,500 shares Expires 2028-03-14 F1 · derivative.exercise_date: This option vests over a four-year period, with 25% to vest on the first anniversary of the grant date and 1/36th of the total remaining number to vest on a monthly basis thereafter, such that the stock option is vested in full on the fourth anniversary of the grant date. Read SEC document |
| March 15, 2017 Filed Feb 9, 2018 22:23 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Options (Right to buy) · Derivative | 80,000 | $0.00 Strike: $45.71 | $0.00 |
DisclosureSEC source: 0001562180-18-000713 · primarydocument.xml · derivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-03-15 F1 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% will vest on the first year anniversary date of the grant and then will vest equally for 36 months thereafter, such that the stock option is vested in full on the four-year anniversary of the grant date. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Options (Right to buy) · Derivative | 3,723 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · derivative · entry 6 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,723 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vested equally for 12 months thereafter, such that the stock option vested in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,723 | $40.03 | $149,031.69 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.245. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 3,723 | $7.28 | $27,084.83 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.